{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:55:43Z","timestamp":1775073343243,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,19]]},"abstract":"<jats:p>Members of the transforming growth factor-\u03b2 superfamily, such as growth differentiation factor 15 (GDF-15), are potent regulators of vascular remodeling and play key roles in atherosclerosis. In this study, we investigated the effect of GDF-15 level on the extent and severity of atherosclerosis in patients with peripheral artery disease (PAD) without obstructive coronary artery disease. A total of 130 patients with PAD who were admitted to the cardiology outpatient department of Biruni University Health Center with complaints of chest pain and intermittent claudication, and whose coronary artery disease was excluded after coronary angiography, were included. GDF-15 levels were measured, and the TASC-2, Rutherford, and Fontaine classifications of patients with obstructive PAD patients were performed. Although there were no statistically significance between 5 Fontaine classes, 3 categories of Rutherford classification and 4 groups of TASC-2 in terms of BMI, platelet count, monocyte\/HDL ratio, CRP, and GDF-15 levels were significantly increased. Furthermore, we also performed a regression analysis of parameters that reached statistical significance between the PAD(+) and PAD(\u2212) groups to analyze the independent risk factors for obstructive PAD and lower extremity ulcers. Although none of the mentioned parameters were found to be independent risk factors for obstructive PAD, CRP ([<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.006, \u03b2: 1.098, OR [(95% CI): 1.027\u20131.174]) and GDF-15 ([<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002, \u03b2: 1.002, OR [(95% CI): 1.004\u20131.010]) were shown to be independent risk factors for lower- extremity ulcers. Our prospective study postulated that CRP and GDF-15 levels are elevated in patients with obstructive PAD and they are independent risk factors for lower-extremity ulcers.<\/jats:p>","DOI":"10.1097\/md.0000000000044530","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:00:53Z","timestamp":1758574853000},"page":"e44530","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Effect of growth differentiation factor-15 (GDF-15) level on extent and severity of atherosclerosis in peripheral arterial disease patients free of obstructive coronary artery disease: A cross-sectional observational study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4467-9919","authenticated-orcid":false,"given":"Emrah","family":"Ozdemir","sequence":"first","affiliation":[{"name":"Department of Cardiology, Biruni University Faculty of Medicine, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4032-7561","authenticated-orcid":false,"given":"Murat","family":"Ziyrek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, KTO Karatay University Faculty of Medicine, Konya, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250928","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nri3520","article-title":"Macrophages in atherosclerosis: a dynamic balance.","volume":"13","author":"Moore","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"R2-20250928","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options.","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"R3-20250928","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease.","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ Res"},{"key":"R4-20250928","doi-asserted-by":"crossref","first-page":"490842","DOI":"10.1155\/2015\/490842","article-title":"GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective.","volume":"2015","author":"Adela","year":"2015","journal-title":"J Diabetes Res"},{"key":"R5-20250928","doi-asserted-by":"crossref","first-page":"6497568","DOI":"10.1155\/2021\/6497568","article-title":"GDF-15 suppresses atherosclerosis by inhibiting oxLDL-induced lipid accumulation and inflammation in macrophages.","volume":"2021","author":"Huang","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R6-20250928","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","article-title":"The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases.","volume":"28","author":"Tsai","year":"2018","journal-title":"Cell Metab"},{"key":"R7-20250928","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1474-9726.2010.00629.x","article-title":"Macrophage inhibitory cytokine-1 (MIC-1\/GDF15): a new marker of all-cause mortality.","volume":"9","author":"Wiklund","year":"2010","journal-title":"Aging Cell"},{"key":"R8-20250928","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1161\/CIRCULATIONAHA.112.129437","article-title":"Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.","volume":"126","author":"Wang","year":"2012","journal-title":"Circulation"},{"key":"R9-20250928","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/MAJ.0b013e318291cd4e","article-title":"Growth-differentiation factor- 15 and major cardiac events.","volume":"347","author":"Lin","year":"2014","journal-title":"Am J Med Sci"},{"key":"R10-20250928","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: epidemiology and evidence\u2010based facts.","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"key":"R11-20250928","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease.","volume":"116","author":"Criqui","year":"2015","journal-title":"Circ Res"},{"key":"R12-20250928","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0034-1393976","article-title":"Overview of classification systems in peripheral artery disease.","volume":"31","author":"Hardman","year":"2014","journal-title":"Semin Intervent Radiol"},{"key":"R13-20250928","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version.","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"R14-20250928","first-page":"499","article-title":"Surgical treatment of peripheral circulation disorders [in German].","volume":"21","author":"Fontaine","year":"1954","journal-title":"Helv Chir Acta"},{"key":"R15-20250928","first-page":"e15094","article-title":"Peripheral artery disease as a predictor of coronary artery disease in patients undergoing coronary angiography.","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"},{"key":"R16-20250928","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2019.10.017","article-title":"Body mass index and peripheral artery disease.","volume":"292","author":"Heffron","year":"2020","journal-title":"Atherosclerosis"},{"key":"R17-20250928","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11886-019-1129-5","article-title":"Dyslipidemia profiles in patients with peripheral artery disease.","volume":"21","author":"Aday","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"R18-20250928","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00001721-199603000-00011","article-title":"Platelet size: measurement, physiology and vascular disease.","volume":"7","author":"Bath","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R19-20250928","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1161\/01.ATV.19.3.672","article-title":"A role for changes in platelet production in the cause of acute coronary syndromes.","volume":"19","author":"Van der Loo","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-20250928","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ahj.2007.04.060","article-title":"Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension.","volume":"154","author":"Shankar","year":"2007","journal-title":"Am Heart J"},{"key":"R21-20250928","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.amjcard.2005.04.038","article-title":"Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.","volume":"96","author":"Vu","year":"2005","journal-title":"Am J Cardiol"},{"key":"R22-20250928","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1007\/s11033-011-1182-7","article-title":"GDF-15 promotes angiogenesis through modulating p53\/HIF-1a signaling pathway in hypoxic human umbilical vein endothelial cells.","volume":"39","author":"Song","year":"2012","journal-title":"Mol Biol Rep"},{"key":"R23-20250928","doi-asserted-by":"crossref","first-page":"e006225","DOI":"10.1161\/JAHA.117.006225","article-title":"Growth differentiation factor 15 is associated with major amputation and mortality in patients with peripheral artery disease.","volume":"6","author":"De Haan","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:26Z","timestamp":1759046546000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":23,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044530","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2025-05-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}